Anna Protopapas
Chairman at NUVALENT, INC.
Net worth: 1 M $ as of 2024-04-29
Anna Protopapas active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MERSANA THERAPEUTICS, INC. | Director/Board Member | 2015-03-01 | - |
| Chief Executive Officer | 2015-03-01 | 2023-09-09 | |
| President | 2015-03-01 | 2023-09-09 | |
| NUVALENT, INC. | Chairman | 2022-03-29 | - |
| Independent Dir/Board Member | 2022-03-29 | - |
Career history of Anna Protopapas
Former positions of Anna Protopapas
| Companies | Position | Start | End |
|---|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Director/Board Member | 2019-01-22 | 2021-06-02 |
| Independent Dir/Board Member | 2019-01-22 | 2021-06-02 | |
| BIOVERATIV INC | Director/Board Member | 2017-02-27 | 2018-03-07 |
| ARIAD PHARMACEUTICALS, INC. | Director/Board Member | 2015-03-31 | 2017-01-15 |
| Independent Dir/Board Member | 2015-03-31 | 2017-01-15 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Executive Officer | 2013-07-04 | 2014-09-30 |
| Corporate Officer/Principal | 1997-09-30 | 2013-07-04 | |
| President | 2013-07-04 | 2014-09-30 | |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Corporate Officer/Principal | 2011-07-28 | 2014-09-30 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2010-09-30 | 2014-09-30 |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Training of Anna Protopapas
| Princeton University | Undergraduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Statistics
International
| United States | 11 |
| Japan | 2 |
| 2 |
Operational
| Director/Board Member | 5 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| MERSANA THERAPEUTICS, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Ensemble Therapeutics Corp.
Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Commercial Services |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
| Nuvalent, Inc. |
- Stock Market
- Insiders
- Anna Protopapas
- Experience